FDA 483 - Monarch PCM, LLC - August 20, 2021
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Monarch PCM, LLC was cited for significant deficiencies across its drug product and dietary supplement manufacturing operations. The firm repeatedly released drug products that failed to meet specifications, lacked adequate quality control oversight, and failed to properly investigate and prevent microbial contamination, particularly Burkholderia cepacia complex, in its water systems and equipment. Additionally, the inspection revealed issues with incomplete laboratory records, unvalidated reprocessing procedures, and inadequate product specifications and supplier qualification for dietary supplements.
ID · a99481c5-4df3-44c2-a5c4-c20b3fedbfee